Effect of laminin tyrosine-isoleucine-glycine-serine-arginine peptide on the growth of human prostate cancer (PC-3) cells in vitro

European Journal of Pharmacology

Volumn 616, Issue 1-3, 2009, Pages 251-255

  Yu, Hai ning ^a,b   Zhang, Lan cui ^b   Yang, Jun guo ^b   Das, Undurti N ^c,d   Shen, Sheng rong ^b  

^a ZHEJIANG UNIVERSITY OF TECHNOLOGY   (China)

^b ZHEJIANG UNIVERSITY   (China)

^c UND LIFE SCIENCES   (United States)

^d JAWAHARLAL NEHRU TECHNOLOGICAL UNIVERSITY   (India)

Author keywords

67LR; EGCG; PC 3 cell; YIGSR

Indexed keywords

ADENOSINE TRIPHOSPHATE; ANTINEOPLASTIC AGENT; CASPASE 9; EPIGALLOCATECHIN GALLATE; LAMININ RECEPTOR; LAMININ TYROSYLISOLEUCYLGLYCYLSERYLARGININE PEPTIDE; POLYPHENOL; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BINDING SITE; CANCER CELL CULTURE; CANCER INHIBITION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG RECEPTOR BINDING; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IN VITRO STUDY; LIGAND BINDING; MALE; MIGRATION INHIBITION; MITOCHONDRIAL MEMBRANE POTENTIAL; MOLECULAR DOCKING; PRIORITY JOURNAL; PROSTATE CANCER;

ADENOSINE TRIPHOSPHATE; AMINO ACID SEQUENCE; ANDROGENS; CASPASE 9; CATECHIN; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; HUMANS; LAMININ; MALE; MEMBRANE POTENTIAL, MITOCHONDRIAL; MODELS, MOLECULAR; MOLECULAR CONFORMATION; OLIGOPEPTIDES; PROSTATIC NEOPLASMS; RECEPTORS, LAMININ;

EID: 67651175835     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2009.06.050     Document Type: Article

References (31)

1. Ardini E., Sporchia B., Pollegioni L., Modugno M., Ghirelli C., Castiglioni F., Tagliabue E., and Menard S. Identification of a novel function for 67-kDa laminin receptor: Increase in laminin degradation rate and release of motility fragments. Cancer Res. 62 (2003) 1321-1325
2. Armstrong J.S. The role of the mitochondrial permeability transition in cell death. Mitochondrion. 6 (2006) 225-234
3. Bilozur M.E., and Hay E.D. Neural crest migration in 3D extracellular matrix utilizes laminin, fibronectin, or collagen. Dev. Biol. 125 (1988) 19-33
4. Castronovo V. Laminin receptors and laminin-binding proteins during tumor invasion and metastasis. Invasion Metastasis. 3 (1993) 1-3
5. Christopher R.A., Judge S.R., Vincent P.A., Higgins P.J., and McKeown-Longo P.J. The amino-terminal matrix assembly domain of fibronectin stabilizes cell shape and prevents cell cycle progression. J. Cell. Sci. 112 (1999) 3225-3235
6. Freitas V.M., and Jaeger R.G. The effect of laminin and its peptide SIKVAV on a human salivary gland adenoid cystic carcinoma cell line. Virchows Arch. 441 (2002) 569-576
7. Fujimura Y., Umeda D., Kiyohara Y., Sunada Y., Yamada K., and Tachibana H. The involvement of the 67 kDa laminin receptor-mediated modulation of cytoskeleton in the degranulation inhibition induced by epigallocatechin-3-O-gallate. Biochem. Biophys. Res. Commun. 348 (2006) 524-531
8. Fujimura Y., Yamada K., and Tachibana H. A lipid raft-associated 67 kDa laminin receptor mediates suppressive effect of epigallocatechin-3-O-gallate on FcepsilonRI expression. Biochem. Biophys. Res. Commun. 336 (2005) 674-681
9. Gauczynski S., Peyrin J.M., Haïk S., Leucht C., Hundt C., Rieger R., Krasemann S., Deslys J.P., Dormont D., Lasmézas C.I., and Weiss S. The 37-kDa/67-kDa laminin receptor acts as the cell-surface receptor for the cellular prion protein. EMBO J. 20 (2001) 5863-5875
10. Graf J., Ogle R.C., Robey F.A., Sasaki M., Martin G.R., Yamada Y., and Kleinman H.K. A pentapeptide from the laminin B1chain mediates cell adhesion and binds 67000 laminin receptor. Biochemistry. 26 (1989) 6896-6900
11. Hadley M.A., Weeks B.S., Kleinman H.K., and Dym M. Laminin promotes formation of cord-like structures by sertoli cells in vitro. Dev. Biol.140 318-327 (1990)
12. Iwamoto Y., Nomizu M., Yamada Y., Ito Y., Tanaka K., and Sugioka Y. Inhibition of angiogenesis, tumour growth and experimental metastasis of human fibrosarcoma cells HT1080 by a multimeric form of the laminin sequence Tyr-Ile-Gly-Ser-Arg (YIGSR). Br. J. Cancer. 73 (1996) 589-595
13. Iwamoto Y., Robey F.A., Graf J.M., Sasaki M., Kleinman H.K., Yamada Y., and Martin G.R. YIGSR, a pentapeptide from B1 chain of laminin inhibits tumor cell metastases. Science. 238 (1987) 1132-1134
14. Khan N., and Mukhtar H. Multitargeted therapy of cancer by green tea polyphenols. Cancer Lett. 269 (2008) 269-280
15. Kim W.H., Schnaper H.W., Nomizu M., Yamada Y., and Kleinman H.K. Apoptosis in human fibrosarcoma cells is induced by a multimeric synthetic Tyr-Ile-Gly-Ser-Arg (YIGSR)-containing polypeptide from laminin. Cancer Res. 54 (1994) 5005-5010
16. Kitchen D.B., Decornez H., Furr J.R., and Bajorath J. Docking and scoring in virtual screening for drug discovery; methods and applications. Nat. Rev. Drug Discov. 3 (2004) 935-949
17. Leach A.R., Shoichet B.K., and Peishoff C.E. Prediction of protein-ligand interactions. Docking and scoring: Successes and gaps. J. Med. Chem. 49 (2006) 5851-5855
18. Michigami T., Nomizu M., Yamada Y., Dunstan C., Williams P.J., Munday G.R., and Yoneda T. Growth and dissemination of a newly-established murine B-cell lymphoma cell line is inhibited by multimeric YIGSR peptide. Clin. Exp. Metastasis. 16 (1998) 645-654
19. Morais Freitas V., Nogueira da Gama de Souza L., Cyreno Oliveira E., Furuse C., Cavalcanti de Araújo V., and Gastaldoni Jaeger R. Malignancy-related 67 kDa laminin receptor in adenoid cystic carcinoma. Effect on migration and beta-catenin expression. Oral Oncol. 43 (2007) 987-9833
20. Nelson J., McFerran N.V., Pivato G., Chambers E., Doherty C., Steele D., and Timson D.J. The 67 kDa laminin receptor: Structure, function and role in disease. Biosci. Rep. 28 (2008) 33-48
21. Pripp A.H. Docking and virtual screening of ACE inhibitory dipeptides. Eur. Food Res. Technol. 225 (2007) 589-592
22. Sabzali J., and Morris K. Mitochondrial permeability transition pore opening as an endpoint to initiate cell death and as a putative target for cardioprotection. Cell Physiol. Biochem. 20 (2007) 01-22
23. Sobel M.E. Differential expression of the 67 kDa laminin receptor in cancer. Semin. Cancer Biol. 4 (1993) 311-317
24. Tachibana H., Koga K., Fujimura Y., and Yamada K. A receptor for green tea polyphenol EGCG. Nat. Struct. Mol. Biol. 11 (2004) 380-381
25. Tatsumi T., Shiraishi J., Keira N., Akashi K., Mano A., Yamanaka S., Matoba S., Fliss H., and Nakagawa M. Intracellular ATP is required for mitochondrial apoptotic pathways in isolated hypoxic rat cardiac myocytes. Cardiovasc. Res. 59 (2003) 428-440
26. Timpl R., Rohde H., Robey P.G., Rennard S.I., Foidart J.M., and Martin G.R. Laminin: A glycoprotein from basement membranes. J. Bio. Chem. 254 (1979) 9933-9937
27. Umeda D., Tachibana H., and Yamada K. Epigallocatechin-3-O-gallate disrupts stress fibers and the contractile ring by reducing myosin regulatory light chain phosphorylation mediated through the target molecule 67 kDa laminin receptor. Biochem. Biophys. Res. Commun. 333 (2005) 628-635
28. Xiaodong W. The expanding role of mitochondria in apoptosis. Genes Dev. 15 (2001) 2922-2933
29. Yamamura K., Kibbey M.C., Jun S.H., and Kleinman H.K. Effect of matrigel and laminin peptide YIGSR on tumor growth and metastasis. Semin. Cancer Biol. 4 (1993) 259-265
30. Yoshihide T., Takashi N., and Shigeomi S. Mitochondrial membrane permeability transition and cell death. Biochim. Biophys. Acta 1757 (2006) 1297-1300
31. 2+ in vitro. Toxicol. In Vitro. 22 (2008) 953-960